-
-
-
-
-
-
-
RBC Capital Downgrades Telix Pharmaceuticals Ltd (TLX:AU) (TLX) to Sector Perform
-
-
-
-
-
-
-
Telix partners with EDAP and Profound on prostate imaging tech
-
-
-
-
-
-
-
FDA accepts Telix brain cancer imaging drug application
-
-
-
-
-
-
-
Telix's TLX250-CDx imaging agent included in international renal guidelines
-
-
-
-
-
-
-
JPMorgan Downgrades Telix Pharmaceuticals Ltd (TLX) to Neutral
-
-
-
-
-
-
-
Trans-lux Corporation (TLX) Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
-
457,655 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

